The Hordaland homocysteine studies

Lipids

Volumn 36, Issue SUPPL., 2001, Pages

  Ueland, Per Magne ^a   Nygård, Ottar ^a   Vollset, Stein Emil ^a   Refsum, Helga ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CARDIOVASCULAR SYSTEM; CHOLESTEROL; DISEASES; NUTRITION; PATIENT MONITORING; VITAMINS;

CARDIOVASCULAR RISKS;

AMINO ACIDS;

CHOLESTEROL; FOLIC ACID; HOMOCYSTEINE; VITAMIN;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; AMINO ACID BLOOD LEVEL; BLOOD PRESSURE; CANCER INCIDENCE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; DIET; FEMALE; GENDER; HUMAN; LIFESTYLE; MALE; MASS SCREENING; MORBIDITY; MORTALITY; NORWAY; PHYSICAL ACTIVITY; PREGNANCY COMPLICATION; RISK FACTOR; SMOKING;

EID: 0035698454     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-001-0679-7     Document Type: Conference Paper

References (62)

1. Homocysteine and other thiols in plasma and urine: Automated determination and sample stability
2. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study
3. Serum total homocysteine concentrations in adolescent and adult Americans: Results from the Third National Health and Nutrition Examination Survey
4. Serum total homocysteine concentrations in the Third National Health and Nutrition Examination Survey (1991-1994): Population reference ranges and contribution of vitamin status to high serum concentrations
5. Determinants of plasma homocysteine
6. Serum total homocysteine and coronary heart disease
7. Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease
8. Homocysteine and cardiovascular disease
9. Plasma total homocysteine levels during short-term iatrogenic hypothyroidism
10. Homocysteine and cysteine: Determinants of plasma levels in middle-aged and elderly subjects
11. Plasma total homocysteine in healthy subjects: Sex-specific relation with biological traits
12. Folate intake, lifestyle factors, and homocysteine concentrations in younger and older women
13. Lifestyle factors associated with hyperhomocysteinemia
14. Major lifestyle determinants of plasma total homocysteine distribution: The Hordaland Homocysteine Study
15. Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50. Effect of smoking and extent of disease
16. Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease
17. Redox status and protein-binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease
18. Plasma homocysteine and cardiovascular disease
19. The Hordaland Homocysteine Study: Lifestyle and total plasma homocysteine in Western Norway
20. Elevated homocysteine levels in alcohol withdrawal
21. Homocysteine and ischaemic heart disease in the Caerphilly cohort
22. Effect of consumption of red wine, spirits, and beer on serum homocysteine
23. C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): Its frequency and impact on plasma homocysteine concentration in different European populations
24. Effect of acute exercise on plasma homocysteine
25. Influence of exercise and menstrual cycle phase on plasma homocyst(e)ine levels in young women - A prospective study
26. Coffee consumption and total plasma homocysteine. The Hordaland Homocysteine Study
27. Association of dietary protein intake and coffee consumption with serum homocysteine concentrations in an older population
28. Determinants of plasma total homocysteine concentration in the framingham offspring cohort
29. Coffee consumption and plasma homocyst(e)ine: Results from the atherosclerosis risk in communities study
30. Unfiltered coffee increases plasma homocysteine concentrations in healthy volunteers: A randomized trial
31. Heavy coffee consumption and plasma homocysteine: A randomized controlled trial in healthy volunteers
32. Metabolic abnormalities in cobalamin (vitamin-B 12) and folate deficiency
33. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials
34. The effect of different treatment regimens in reducing fasting and postmethionine-load homocysteine concentrations
35. Low dose vitamin B6 effectively lowers fasting plasma homocysteine in healthy elderly people who are folate and riboflavin replete
36. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
37. Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (≥40 μmol/liter). The Hordaland Homocysteine Study
38. Biological and clinical implications of the MTHFR C677T polymorphism
39. Riboflavin as a determinant of plasma total homocysteine: Effect modification by the methylenetetrahydrofolate reductase C677T polymorphism
40. Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: The Hordaland Homocysteine Study
41. The relation between plasma cysteine, plasma homocysteine and coronary atherosclerosis
42. Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects
43. Blood glutathione and cysteine changes in cardiovascular disease
44. Homocysteine species as components of plasma redox thiol status
45. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: The Hordaland Homocysteine Study
46. Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: A systematic review
47. Folic acid: Influence on the outcome of pregnancy
48. Hyperhomocysteinemia and pregnancy-review of our present understanding and therapeutic implications
49. Plasma homocysteine levels and mortality in patients with coronary artery disease
50. Nutritional aspects and possible pathological mechanisms of hyperhomocysteinaemia: An independent risk factor for vascular disease
51. Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease
52. Increased plasma homocysteine is an independent predictor of new coronary events in older persons
53. Increased plasma homocysteine is an independent predictor of new atherothrombotic brain infarction in older persons
54. Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: A prospective study
55. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-Year follow-up of the Hoorn Study
56. Plasma homocysteine and all-cause mortality in diabetes
57. Homocysteine, lipoprotein(a), and restenosis after percutaneous transluminal coronary angioplasty: A prospective study
58. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
59. Plasma total homocysteine and hemodialysis access thrombosis: A prospective study
60. Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients
61. Plasma total homocysteine concentration and the risk of acute coronary events: The Kuopio Ischaemic Heart Disease Risk Factor Study
62. The controversy over homocysteine and cardiovascular risk